Automated Breast Ultrasound Systems (ABUS) Market Market Growth Analysis, Opportunities Forecasts Report to 2030 | General Electric Co., Siemens AG, Hitachi Ltd., QT Ultrasound LLC

Automated Breast Ultrasound Systems (ABUS) Market, By Region (Africa, Latin America, Asia Pacific, the Middle East, Europe, North America) – Share, Size, Outlook, and Opportunity Analysis, 2019–2027

High-frequency sound waves are utilized in ultrasound to evaluate the body’s internal organs and structures, and radiation exposure is not involved. Automated breast ultrasound employs a transducer that scans the entire breast to acquire three-dimensional (3D) ultrasound images for the purpose of detecting cancer.

The global automated breast ultrasound system (ABUS) market is expected to reach US$ 271.1 million and a volume of 1,270 units by the end of 2030.

Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/78

Market Drivers

The rise in breast cancer cases is a key driver for the growth of the automated breast ultrasound system (ABUS) market worldwide. As per the World Health Organization, every year, breast cancer affects 2.1 million women globally, resulting in 627,000 deaths in 2018 alone.

The market is anticipated to experience growth as a result of the rising efforts from both government and private organizations to promote breast cancer awareness. As an example, AMMETLIFE Insurance Bhd initiated a fundraising drive in December 2019 to provide support for the Pink Ribbon Wellness (L) Foundation’s breast cancer awareness initiatives.

In 2018, the North American region secured the leading position in the global automated breast ultrasound system (ABUS) market, with a value share of 41.6%, followed by Europe.

Market Restraints

The use of automated breast ultrasound imaging techniques has been limited in several countries due to strict regulations. Additionally, the costly nature of ultrasound systems when compared to traditional cancer screening methods is expected to impede the expansion of the global automated breast ultrasound system (ABUS) market. For instance, a new ABUS machine can cost approximately US$ 300,000 on average.

While ultrasound can rapidly enhance cancer detection, it is also susceptible to producing false-positive biopsies, thereby hindering market growth.

Market Opportunities

Players in the global automated breast ultrasound system (ABUS) market are anticipated to experience profitable growth prospects as there is a rising need for prompt detection and therapy of breast cancer. The National Center for Biotechnology Information (NCBI) has reported that by 2025, females between the ages of 30 and 34 might contribute to a 130.6% rise in the occurrence of breast cancer.

In addition, major market participants may prioritize the incorporation of both full-field digital mammography (FFDM) and ABUS into a unified platform in order to provide superior-quality images.

Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/78

Market Trends/Key Takeaways

Breast cancer is becoming more prevalent among women in North America and Europe. Additionally, due to the low sensitivity of mammography in dense breast tissue, ABUS is being increasingly utilized.

ABUS is being adopted by major hospitals around the world to enhance treatment results. An example is St. Patrick Hospital in Montana, USA, which installed ABUS in November 2019.

Competitive Landscape

Leading companies in the global automated breast ultrasound system (ABUS) market include SonoCiné Inc., Ikonopedia, Siemens AG, QT Ultrasound LLC, Hitachi Ltd., and General Electric Co.

Key Developments

Major players in the market are concentrating on implementing partnership and collaboration techniques to improve their position in the market. As an example, in October 2019, GE Healthcare formed a partnership with Premier Inc. to create a plan for introducing a same-day breast cancer diagnosis and treatment system in the United States.

Key participants in the market are prioritizing the adoption of marketing tactics to improve their portion of the market. As a point in case, during the 105th Annual Radiological Society of North America (RSNA) meeting in December 2019, Ikonopedia showcased improvements to its breast biopsy reporting tool with the aim of enhancing efficiency and clinical utility.

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Research Antibodies Market Size Analysis from 2023 to 2030
11.6 COVID-19 Outbreak: Research Antibodies Industry Impact

Chapter 2 Global Research Antibodies Competition by Types, Applications, and Top Regions and Countries
2.1 Global Research Antibodies (Volume and Value) by Type
2.3 Global Research Antibodies (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Research Antibodies Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Research Antibodies Market Analysis
Chapter 6 East Asia Research Antibodies Market Analysis
Chapter 7 Europe Research Antibodies Market Analysis
Chapter 8 South Asia Research Antibodies Market Analysis
Chapter 9 Southeast Asia Research Antibodies Market Analysis
Chapter 10 Middle East Research Antibodies Market Analysis
Chapter 11 Africa Research Antibodies Market Analysis
Chapter 12 Oceania Research Antibodies Market Analysis
Chapter 13 South America Research Antibodies Market Analysis
Chapter 14 Company Profiles and Key Figures in Research Antibodies Business
Chapter 15 Global Research Antibodies Market Forecast (2023-2030)
Chapter 16 Conclusions
Research Methodology